Immunovant, Inc.
(NASDAQ : IMVT)

( )
IMVT After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Finance » Financial Conglomerates
symbolcompany%chnglast%shortavg$volume
CCitigroup, Inc. -0.86%52.890.9%$1033.32m
AXPAmerican Express Co. -1.23%100.431.7%$375.38m
PRUPrudential Financial, Inc. -0.50%69.561.4%$175.95m
SPAQSpartan Energy Acquisition Corp. -0.57%12.160.0%$96.90m
JAMFJamf Holding Corp. -2.71%38.000.0%$91.39m
BEPCBrookfield Renewable Corp. -1.25%46.730.0%$75.24m
RIOTRiot Blockchain, Inc. 1.98%3.610.0%$56.62m
INGING Groep NV -1.32%8.200.2%$50.83m
EQHEquitable Holdings, Inc. 0.79%21.710.0%$49.88m
SHLLTortoise Acquisition Corp. 21.01%24.080.0%$45.49m
CCXX 0.66%10.760.0%$33.08m
LCALandcadia Holdings II, Inc. 8.87%13.250.0%$32.97m
DPHCDiamondPeak Holdings Corp. 2.62%12.930.0%$32.79m
CNNECannae Holdings, Inc. 0.63%38.260.0%$28.15m
FVAC 1.64%12.100.0%$28.14m

Company Profile

Immunovant, Inc. is a clinical-stage biopharmaceutical company. It focuses on enabling normal lives for patients with autoimmune diseases. The company was founded in 2018 and is headquartered in New York, NY.